Target intelligence / Profile preview

Salmonella (genus)

Molecular classification
Other (Bacterium, member of Enterobacteriaceae; not a molecular drug target)
01

Overview

Salmonella is a genus of rod-shaped, Gram-negative, facultatively anaerobic bacteria within the family Enterobacteriaceae, comprising two principal species: Salmonella enterica and Salmonella bongori. Over 2,500 serovars of S. enterica are classified based on O (somatic), H (flagellar), and sometimes Vi (capsular) antigens. Salmonella causes a spectrum of illnesses in humans and animals including self-limited gastroenteritis (non-typhoidal strains) and systemic diseases like typhoid and paratyphoid fever (typhoidal strains). Transmission is primarily via ingestion of contaminated food or water. The organisms possess multiple virulence factors, including type III secretion systems that enable intracellular survival and immune evasion. Treatment is focused on broad-acting antibiotics for systemic and severe disease, but increasing antimicrobial resistance is a significant concern. Vaccines are available for typhoid fever. Since Salmonella refers to an entire bacterial genus and not a molecular target, it is not a canonical drug target in the context of receptor or enzyme-targeting drugs.

Other names
Salmonella spp.S. entericaS. bongoriSalmonella Typhi (for the serovar S. enterica serovar Typhi)Salmonella Typhimurium (for the serovar S. enterica serovar Typhimurium)Non-typhoidal Salmonella
02

Mechanism of action

Inhibition of bacterial DNA synthesis (e.g., fluoroquinolones like ciprofloxacin) Inhibition of bacterial cell wall synthesis (e.g., β-lactams such as ampicillin, ceftriaxone) Inhibition of bacterial protein synthesis (e.g., macrolides like azithromycin) Immune activation/preventive via vaccination (e.g., Ty21a, Vi polysaccharide)

03

Biological functions

Pathogenesis/infectionImmune system evasionIntracellular survival
04

Disease associations

Infection (salmonellosis, typhoid fever, paratyphoid fever, gastroenteritis)Other (foodborne illness, septicemia)
05

Safety considerations

Rising antibiotic resistanceSevere disease in immunocompromised hostsPotential for invasive and life-threatening infection (esp. typhoidal strains)
06

Interacting drugs

Antibiotics:

6 more in the full profile.

07

Biomarkers

Serological markers (O, H, and Vi antigens for serovar/strain typing)PCR for specific DNA sequencesBlood or stool culture positivity

Beyond the preview

Go deeper on Salmonella (genus).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella (genus).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call